BMRN - BioMarin touts new data on Voxzogo for additional indications
2024-05-06 09:21:31 ET
More on BioMarin Pharmaceutical
- BioMarin Pharmaceutical, Inc. (BMRN) Q1 2024 Earnings Call Transcript
- BioMarin Pharmaceutical Inc. 2024 Q1 - Results - Earnings Call Presentation
- BioMarin Pharmaceutical: Still Has A Lot Of Room For Growth
- BioMarin updated 2024 guidance sees EPS raise, but no change to revenue
- BioMarin Pharmaceutical Non-GAAP EPS of $0.71 beats by $0.11, revenue of $648.83M misses by $2.98M